CTS’s reputation as a reliable partner to multinational companies spans almost 100 years. Thanks to our continued commitment and superior results, we have become a preferred partner for multinational companies seeking to expand their geographic presence and market their products in the Israeli market.
We actively seek new partnerships with multinational companies interested in licensing out their products for the Israeli market with faster commercialization.
How is CTS unique?
CTS puts patients first, and maintains a focused and committed organization that achieves superior and timely results. We are flexible, resourceful and proactive, quickly adapting to change.
Our unique approach is reflected in the way we choose to communicate with patients and customers. In addition to the regular pharmacovigilance reporting system that all pharma companies have in place, we established a customer service organization (including a customer hotline). This enables us to stay close to our customers, understand their needs, and ultimately serve them better.
CTS was also a pioneer in its use of digital. We were the first to set up a corporate Facebook page – in both Hebrew and Arabic. We were the first to make our websites fully accessible to the handicapped, and have been testing advanced data-driven digital marketing, sales tools, and methodologies (to cope with regulatory changes).
Full & Complete End-to-End Solutions
We offer our partners a full & complete service to successfully launch products in the Israeli market including registration, market access, marketing, medico-marketing, medical sales force, manufacturing distribution, and where applicable, local packaging services.
Successful track record of product launches and market penetration
We have demonstrated a successful track record of product launches and market penetration, thanks to our team of highly experienced pharma executives, market access professionals, and medical representatives.
We’ve established excellent long-term relationships with physicians, health maintenance organizations (‘sick funds’), hospitals, payers, pharmacies, and key opinion leaders.
In addition to commercialization, we help our partners reach the right KOLs to conduct clinical trials, discuss potential research collaborations, and find the optimal route to market.
Israel – a Hub of Healthcare Innovation and Research
Israel’s healthcare system is considered one of the most advanced and cost-effective. Israel is also becoming a global leader in the field of medical and clinical research and clinical trials. Every year, around 1500 trials are conducted in Israel, and an estimated 350 million dollars are invested by multinationals in clinical trials in Israeli medical centers.
Our EHR system is considered quite advanced and Israeli cumulative historical data is invaluable, as our HMO payer system stores decades of clinical data for millions of patients. In addition, our healthcare system is known for its track record of adopting and covering new drugs and technologies relatively quickly.
We successfully cooperate with leading international companies such as Vifor Pharma, HRA, JAZZ pharmaceuticals, Astellas, Sanofi- Aventis, AB Biotics, Eusa Pharma, Pari, Geistlich, and others.
CTS has won the 1st prize award in marketing creativity three years in a row (2019-2022) . This prize was given to us by our Swiss partner Geistlich for our launch campaign in the Israeli periodontics market